GLP-1 Receptor Agonists (GLP-1 RAs):Primary mechanism: Mimicking the GLP-1 hormone to regulate appetite, blood sugar, and potentially influencing brain reward pathways.Common side effects: Nausea, vomiting, diarrhea, constipation (often gastrointestinal).Potential benefits for mood: Indirect effects through weight management, reduced "food noise," and possible anti-inflammatory actions
Notably, Eli Lillys 2023 release of tirzepatide marked the first FDA-approved dual GIP and GLP-1 receptor agonist
There was no consistent effect on the length or severity of the common cold (Hemila and Chalker 2013)
For medications like semaglutide, a popular choice in diabetes and weight management treatments, having high-quality labels on each vial ensures that users and healthcare providers can easily read essential information
This log becomes critical when deciding whether to increase, maintain, or decrease your dose
Adv Neurotoxicol